Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects

NCT ID: NCT04655300

Last Updated: 2022-02-15

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 102 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-01-16
• Study Completion Date: 2021-02-05

Brief Summary

Evaluation of age-related skin changes using clinical probe measurements and imaging modalities in Chinese subjects.

Conditions

Age-related Skin Changes

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Group 1

No interventions assigned to this group

Group 2

No interventions assigned to this group

Group 3

No interventions assigned to this group

Group 4

No interventions assigned to this group

Group 5

No interventions assigned to this group

Group 6

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Chinese subjects
• Subject agreeing to complete all study required procedures.
• Subject having given freely and expressly his/her informed consent.

Exclusion Criteria

• Pregnant or nursing woman or planning a pregnancy during the study.
• Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
• Subject in a social or sanitary establishment.
• Subject participating to another research on human beings or being in an exclusion period for a previous study.
• Intensive exposure to sunlight or UV-rays within the previous month and foreseen during the study.
• Subject who underwent tissue augmentation with dermal fillers including HA, calcium hydroxylapatite, autologous fat, mesotherapy, or other cosmetic procedures (eg, face-lift, laser, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, or other ablative procedures) in the face within 12 months before study entry or was planning to undergo any such treatment during the study.
• Subject who underwent treatment with botulinum toxins in the face or neck within 6 months of study entry or was planning to undergo such treatment during the study.
• Subject who ever received semi-permanent fillers or permanent facial implants (eg, poly-L-lactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the face or was planning to be implanted with any of these products at any time during the study.
• Subject with current cutaneous inflammatory or infectious processes (eg, acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the face that could interfere with measurements.
• Subject having changed, started or stopped any hormonal treatment or any treatment likely to have an impact on skin condition (over-the-counter or prescription, oral or topical, anti-wrinkle products on the face), within 30 days prior to enrollment or is planning to begin using such products during the study.

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 79 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Allergan

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Min Liu, MD

Role: PRINCIPAL_INVESTIGATOR

Eurofins China

Locations

Eurofins China

Haizhu, Guangzhou, China

Countries

China

Related Links

https://www.abbvieclinicaltrials.com/search-results/?SearchTerm=NCT04655300&Latitude=&Longitude=&LocationName=&conditions=&Status=&phases=&AgeRanges=&gender=&GenderDescriptions=&StudyTypes=&AttachmentTypes=&MileRadius=100&PageIndex=0&hasResults=&isHighValue=&SortField=&SortOrder=

Clinical Study Report Synopsis

Other Identifiers

2019-605-000

Identifier Type: -

Identifier Source: org_study_id